Table 2

Primary outcome measure for possible randomised controlled trial by assessment time and study group

Quality of lifeStudy groupBaseline
Mean (SD)
Median (IQR)
6 week
Mean (SD)
Median (IQR)
12 week
Mean (SD)
Median (IQR)
24 week
Mean (SD)
Median (IQR)
FACT-G total score22Control52 (9.1)
53 (11.0)
51 (11.2)
56 (17.5)
50 (7.9)
52 (13.0)
48 (12.7)
54 (20.0)
Intervention57 (5.2)
58 (4.0)
56 (6.3)
57 (7.25)
55 (5.5)
56 (4.0)
57 (6.9)
56 (10.5)
Cohen's d effect size (95% CI)0.67 (0.04 to 1.28)0.55 (−0.19 to 1.26)0.73 (−0.07 to 1.49)0.79 (−0.09 to 1.62)
Physical well-being subscaleControl22 (5.8)
24 (7.0)
21 (5.7)
21 (10.5)
22 (5.7)
25 (11.0)
23 (4.5)
24 (7.5)
Intervention23 (4.7)
26 (6.0)
25 (2.4)
26 (4)
25 (3.3)
26 (6.0)
23 (4.7)
25 (4.7)
Cohen's d effect size (95% CI)0.19 (−0.42 to 0.79)0.91 (0.14 to 1.64)0.64 (−0.15 to 1.39)0.00 (−0.82 to 0.82)
Social and family well-being subscaleControl20 (6.1)
21 (11)
19 (7.0)
21 (10.75)
19 (6.2)
19 (10.0)
18 (7.3)
20 (12.5)
Intervention22 (3.6)
23 (6.0)
22 (3.9)
23 (6.0)
22 (4.0)
23 (4.0)
22 (5.5)
23 (8.0)
Cohen's d effect size (95% CI)0.40 (−0.22 to 1.00)0.53 (−0.21 to 1.24)0.57 (−0.22 to 1.32)0.61 (−0.26 to 1.43)
Emotional well-being subscaleControl17 (5.2)
16 (8.0)
18 (4.4)
19 (5.3)
19 (3.8)
19 (6.0)
20 (3.3)
20 (6.5)
Intervention17 (5.5)
19 (7.0)
20 (3.6)
20 (4.0)
20 (3.7)
21 (6.0)
18 (3.8)
18 (6.2)
Cohen's d effect size (95% CI)0.00 (−0.60 to 0.60)0.50 (−0.24 to 1.21)0.27 (−0.50 to 1.02)−0.57 (−1.39 to 0.29)
Functional well-being subscaleControl18 (5.0)
19 (9.0)
17 (6.6)
17.5 (10.3)
19 (6.5)
19 (11.0)
21 (7.6)
23 (14.5)
Intervention21 (6.5)
23 (13.0)
23 (5.6)
26 (8.0)
23 (4.7)
23 (7.0)
23 (5.3)
25 (8.0)
Cohen's d effect size (95% CI)0.52 (−0.11 to 1.12)0.98 (0.20 to 1.71)0.70 (−0.10 to 1.46)0.30 (−0.54 to 1.12)
  • FACT, Functional Assessment of Cancer Therapy-General.